CVS Health (CVS) Tops Q4 EPS by 37c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $94.61 -0.15%
EPS Growth %: +3.1%
Financial Fact:
Net income: 1.54B
Today's EPS Names:
OMID, BCML, CZNC, More
EPS Growth %: +3.1%
Financial Fact:
Net income: 1.54B
Today's EPS Names:
OMID, BCML, CZNC, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q4 EPS of $1.98, $0.37 better than the analyst estimate of $1.61. Revenue for the quarter came in at $76 billion versus the consensus estimate of $74.89 billion.
GUIDANCE:
CVS Health sees FY2022 EPS of $8.10-$8.30, versus the consensus of $8.28.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix shares fall over 5% premarket on soft current-quarter revenue guidance
- Winnebago Industries (WGO) Misses Q4 EPS by 2c; offers guidance
- UDR raises 2026 full-year guidance, reports Q3 preliminary results
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
